Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · IEX Real-Time Price · USD
5.39
+0.29 (5.69%)
May 1, 2024, 4:00 PM EDT - Market closed
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $57.99 million as of May 1, 2024. Its market cap has increased by 15.06% in one year.
Market Cap
57.99M
Enterprise Value
17.47M
1-Year Change
15.06%
Ranking
Category
Stock Price
$5.39
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has decreased from $90.20M to $57.99M, a decrease of -35.71%. That is a compound annual growth rate of -10.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2024 | 54.80M | 3.40% |
Apr 29, 2024 | 53.00M | -10.32% |
Apr 26, 2024 | 59.10M | 0.85% |
Apr 25, 2024 | 58.60M | 1.38% |
Apr 24, 2024 | 57.80M | -6.77% |
Apr 23, 2024 | 62.00M | 0.98% |
Apr 22, 2024 | 61.40M | 6.97% |
Apr 19, 2024 | 57.40M | -7.42% |
Apr 18, 2024 | 62.00M | -3.58% |
Apr 17, 2024 | 64.30M | -0.16% |
Apr 16, 2024 | 64.40M | 0.47% |
Apr 15, 2024 | 64.10M | -6.56% |
Apr 12, 2024 | 68.60M | -4.19% |
Apr 11, 2024 | 71.60M | -13.84% |
Apr 10, 2024 | 83.10M | -0.36% |
Apr 9, 2024 | 83.40M | -0.36% |
Apr 8, 2024 | 83.70M | 0.36% |
Apr 5, 2024 | 83.40M | 7.47% |
Apr 4, 2024 | 77.60M | -16.38% |
Apr 3, 2024 | 92.80M | -5.60% |
Apr 2, 2024 | 98.30M | -3.72% |
Apr 1, 2024 | 102.10M | 8.04% |
Mar 28, 2024 | 94.50M | -10.09% |
Mar 27, 2024 | 105.10M | -2.41% |
Mar 26, 2024 | 107.70M | 1.03% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Hyperfine | 60.85M |
Mural Oncology | 60.58M |
Equillium | 60.29M |
Kronos Bio | 60.10M |
Theratechnologies | 59.77M |
Kezar Life Sciences | 58.60M |
SCYNEXIS | 58.14M |
Cidara Therapeutics | 57.61M |